Cancer

Today’s guest on The Long Run is K. Christopher Garcia. Chris is a professor of molecular and cellular physiology and structural biology at Stanford University and an investigator for the Howard Hughes Medical Institute. To be a bit more specific, you can call him a structural immunologist – the kind of scientist who uses the vivid tools of structural biology...

Are you ready for a bucket list adventure? Join me and a team of biotech executives and investors on the Timmerman Traverse for Damon Runyon Cancer Research Foundation. It’s a trek to Everest Base Camp (17,600 feet) in April 2025. Who’s on the Team? Luke Timmerman, founder & editor, Timmerman Report (team captain) Soufiane Aboulhouda, co-founder and CEO, Nucleate Tamar...

Zach Hornby is today’s guest on The Long Run. Zach is the CEO of San Diego-based Boundless Bio. The company is seeking to target cancer cells in an unusual way. It is developing small molecule drugs that take aim at DNA that resides outside the usual home on a chromosome. These oncogene amplifications occur in loops outside the chromosome. This...

Today’s guest on The Long Run is Robert Ang. Robert is the CEO of Cambridge, Mass.-based Vor Bio. The company is working on what I think you could call an elegant application of CRISPR gene editing for the treatment of acute myeloid leukemia. The idea here takes some explaining but is pretty simple. Patients with acute myeloid leukemia typically get...

This is the time of year when many people sit down and think about the causes they want to support. I’m asking you to consider donating today to young scientists through the Damon Runyon Cancer Research Foundation. Why Young Scientists? Our system for funding science doesn’t do enough to support young people. The average age of a first-time NIH grant...